GlassScriptPhysician profile
Saima Ismaili
NPI 1861660623
$2,325.10
in general payments reported to CMS, 2019-2025
31 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.58 · 2020: $353 · 2021: $191 · 2022: $348 · 2023: $443 · 2024: $597 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,374.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $248.19 | 2019-2022 | |
| Abbvie INC. | $231.31 | 2021-2025 | |
| Bone Support INC. | $212.90 | 2024 | Ceramentbone Void Filler, Cerament G |
| Bioventus LLC | $190.89 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Stryker Corporation | $171.88 | 2023 | Ortholoc 3di |
| Nevro Corp. | $145.61 | 2022-2024 | Senza |
| Paratek Pharmaceuticals, INC. | $141.45 | 2022-2024 | Nuzyra |
| Amgen INC. | $133.57 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $131.39 | 2020-2021 | |
| Smith+Nephew, INC. | $101.20 | 2021-2023 | Grafix Pl |
| Kerecis Limited | $92.90 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Bard Peripheral Vascular, INC. | $76.95 | 2025 | Crosser Iq |
| Treace Medical Concepts, INC. | $65.54 | 2024-2025 | |
| Globus Medical, INC. | $43.36 | 2025 | Senza |
| Abbott Laboratories | $32.57 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $31.23 | 2023 | Qutenza |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.16 | 2020-2023 | Jublia |
| Grt US Holding, INC. | $30.02 | 2022 | |
| Mimedx Group, INC. | $23.30 | 2025 | |
| Inari Medical, INC. | $22.57 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $19.43 | 2024 | |
| Axogen | $18.61 | 2020 | |
| Allergan, INC. | $18.02 | 2020 | |
| Horizon Therapeutics Plc | $16.77 | 2023 | Krystexxa |
| Innovation Technologies INC | $15.04 | 2025 | Irrisept |
| Zyla Life Sciences, INC. | $14.61 | 2019 | |
| Merck Sharp & Dohme LLC | $14.46 | 2019 | |
| Medtronic, INC. | $13.74 | 2022 | |
| Kci USA, INC. | $12.99 | 2020 | |
| Misonix INC | $12.16 | 2021 | |
| Hydrofera LLC | $11.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saima Ismaili listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.